Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Oct 18, 2024  4 days, 18 minutes ago

New Study Unveils the Power of Rosmarinic Acid in Combating Salmonella Infections

2813 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
New Study Unveils the Power of Rosmarinic Acid in Combating Salmonella Infections
Nikhil Prasad  Fact checked by:Thailand Medical News Team Oct 18, 2024  4 days, 18 minutes ago
Herbs And Phytochemicals: Rosmarinic Acid Found to Reduce Inflammation and Restore Gut Health
A team of researchers from Guangxi University, China, have made significant strides in fighting Salmonella infections, revealing that Rosmarinic Acid (RA), a natural compound, can effectively reduce inflammation and restore balance in gut health. This Herbs And Phytochemicals news report delves into the study findings and explains how Rosmarinic Acid (RA) could serve as a promising alternative in addressing the growing threat of antibiotic-resistant bacteria.


Herbs-Phytochemicals-New-Study-Unveils-the-Power-of-Rosmarinic-Acid-in-Combating-Salmonella-Infections

The research team, led by Dandan Yi and Jiakang He, conducted an in-depth study to assess the protective effects of RA against inflammation caused by Salmonella enteritidis (SE). SE is a leading cause of acute gastroenteritis, posing a serious threat to both human and animal health. The study showed that Rosmarinic Acid (RA) not only reduced inflammation but also maintained gut microbiota balance, a key factor in combating infections.
 
Antibiotic Resistance: A Growing Concern
With the increasing misuse of antibiotics, controlling SE infections has become a challenge. Over time, the overuse of antibiotics has led to the rise of drug-resistant strains, making treatment difficult. This is where RA comes into play. The study's findings indicate that Rosmarinic Acid, a phenolic acid with antioxidant, anti-inflammatory, and antibacterial properties, offers an alternative to conventional antibiotics. Rosmarinic acid is a polyphenol phytochemical found in  of many culinary herbs, including rosemary (Salvia rosmarinus L.), perilla (Perilla frutescens L.), sage (Salvia officinalis L.), mint (Mentha arvense L.), and basil (Ocimum basilicum L.).
 
How the Study Was Conducted
The researchers conducted a series of experiments on RAW264.7 cells, MCECs (mouse colonic epithelial cells), and BALB/c mice. They aimed to observe how RA influences SE-induced inflammation and gut microbiota imbalances.
 
The study revealed several key outcomes:
 
-Increased Phagocytic Ability: RA enhanced the ability of RAW264.7 cells to engulf and neutralize harmful bacteria.
 
-Reduced Bacterial Invasion: The compound reduced SE's ability to adhere to and invade mouse intestinal cells.
 
-Anti-inflammatory Effects: RA significantly decreased inflammatory responses caused by SE, including the reduction of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.
 
-Gut Microbiota Restoration: Perhaps most impressively, RA maintained the balance of gut microbiota, which is crucial for overall gut health.
 
These findings are particularly exciting because they open up possibilities for new tre atments that don’t rely solely on antibiotics, which are increasingly becoming less effective due to bacterial resistance.
 
Understanding the Role of TLR9 and NF-κB
One of the most important discoveries made by the research team was the mechanism by which RA works. SE infections typically activate the NF-κB signaling pathway, leading to inflammation. However, RA was found to inhibit this pathway by upregulating TLR9, a receptor that helps recognize harmful bacterial DNA.
 
In the study, it was observed that blocking TLR9 prevented RA from providing its protective effects, suggesting that the regulation of TLR9 is crucial for combating SE. The RA treatment was effective in inhibiting inflammation through the suppression of key signaling molecules, including p-p65 and p-IκB-α, which are responsible for activating the inflammatory response.
 
This intricate mechanism shows that RA not only fights SE infections but also helps in reducing the inflammation associated with bacterial invasion, ultimately protecting the intestinal lining and reducing the risk of further complications.
 
Protective Effects in Mice
The study also included in vivo experiments where mice were pretreated with RA before being exposed to SE. The results were encouraging. Mice treated with RA experienced:
 
-Decreased Mortality: RA significantly improved survival rates in SE-infected mice.
 
-Improved Gut Health: The length of the colon in treated mice was preserved, while untreated mice showed shortening and damage.
 
-Reduced Intestinal Inflammation: Histological analysis of the duodenum and colon revealed that RA reduced tissue damage, keeping the intestinal barrier intact.
 
Furthermore, RA also alleviated oxidative stress by boosting the levels of superoxide dismutase (SOD) and reducing levels of harmful molecules like malondialdehyde (MDA), which are known to contribute to chronic inflammation.
 
Gut Microbiota: A Key Factor
The researchers emphasized the critical role of gut microbiota in fighting SE infections. Healthy gut bacteria serve as a defense mechanism, helping to prevent pathogens like SE from taking over. The study showed that RA not only prevented inflammation but also increased the diversity of beneficial gut bacteria.
 
Mice pretreated with RA showed increased levels of beneficial bacteria such as Firmicutes and Acidibacteria and decreased harmful bacteria like Proteobacteria and Bacteroidota. This change in gut flora was crucial in protecting the mice from severe SE infections.
 
Interestingly, when the researchers cleared the gut microbiota of some mice using antibiotics, RA lost its protective effects, highlighting the importance of a healthy gut microbiota in fighting infections.
 
Potential Applications and Future Research
These findings could have a wide range of applications, particularly in the food and healthcare industries. Since RA is a natural compound found in many herbs, it could be developed into supplements or incorporated into foods to prevent SE infections, particularly in livestock and humans.
 
Moreover, RA’s ability to regulate gut microbiota could be leveraged in developing treatments for other gut-related diseases and infections. Researchers believe that this study lays the groundwork for further research into how natural compounds like RA can be used to fight bacterial infections without contributing to antibiotic resistance.
 
Conclusion
The study concluded that Rosmarinic Acid could be a promising solution for treating SE infections and inflammation without relying on traditional antibiotics. By regulating the TLR9/NF-κB signaling pathway and restoring the balance of gut microbiota, RA provides a natural and effective approach to combat bacterial infections. The research suggests that RA could be developed as a viable alternative to antibiotics, particularly in managing drug-resistant bacterial infections.
 
The study findings were published in the peer-reviewed journal: Antioxidants.
https://www.mdpi.com/2076-3921/13/10/1265
 
For the latest on Herbs And Phytochemicals, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/singapore-led-study-finds-papaya-leaf-extract-effective-against-coronaviruses-and-inflammation
 
https://www.thailandmedical.news/news/university-of-mississippi-study-shows-that-juice-of-the-cornelian-cherry-can-help-with-glioblastoma
 
https://www.thailandmedical.news/news/blueberries-could-hold-the-key-to-stroke-recovery

MOST READ

Jul 25, 2024  3 months ago
Nikhil Prasad
Jul 24, 2024  3 months ago
Nikhil Prasad
Jun 10, 2023  1 year ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  2 years ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer